Previous

From repair to risk: maternal-fetal outcomes after hysteroscopic treatment of Asherman syndrome
Next

Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial